Search research articles
Contact Us
Filters
Showing results (41-50 of 95) with videos related to
Page
of 10
Sort By:
Medical Microbiology and Immunology
|
August 11, 2010
Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis
T Biru, T Lennemann, M Stürmer, et al.
European Journal of Medical Research
|
December 16, 2010
Mutations in the C-terminal region of the HIV-1 reverse transcriptase and their correlation with drug resistance associated mutations and antiviral treatment
I Michels, S Staszewski, L Gürtler, et al.
European Journal of Medical Research
|
July 6, 2006
Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adults
Nils von Hentig, A Müller, C Rottmann, et al.
International Journal of STD & AIDS
|
March 3, 2007
Dose reduction effective in alleviating symptoms of saquinavir toxicity
C Stephan, A Carlebach, C Rottmann, et al.
European Journal of Medical Research
|
October 26, 2011
Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study
S Esser, A Haberl, F Mulcahy, et al.
AIDS (London, England)
|
March 15, 1997
Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials
S Staszewski, A M Hill, J Bartlett, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1998
Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride
V Miller, M P de Béthune, A Kober, et al.
Intervirology
|
January 1, 1997
Increased serum and mRNA levels of RANTES associated with elevated levels of activated CD8+CD38+ T cells in HIV-1 infected individuals
P Müller, M Engelstädter, A Werner, et al.
Journal of Virology
|
April 1, 1995
Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals
D W Lineberger, J A Kessler, J A Waterbury, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Resistance profiles in patients with viral rebound on potent antiretroviral therapy
A Cozzi Lepri, C A Sabin, S Staszewski, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 95) with videos related to
Sort By:
Page
of 10
Medical Microbiology and Immunology
|
August 11, 2010
Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis
T Biru, T Lennemann, M Stürmer, et al.
European Journal of Medical Research
|
December 16, 2010
Mutations in the C-terminal region of the HIV-1 reverse transcriptase and their correlation with drug resistance associated mutations and antiviral treatment
I Michels, S Staszewski, L Gürtler, et al.
European Journal of Medical Research
|
July 6, 2006
Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adults
Nils von Hentig, A Müller, C Rottmann, et al.
International Journal of STD & AIDS
|
March 3, 2007
Dose reduction effective in alleviating symptoms of saquinavir toxicity
C Stephan, A Carlebach, C Rottmann, et al.
European Journal of Medical Research
|
October 26, 2011
Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study
S Esser, A Haberl, F Mulcahy, et al.
AIDS (London, England)
|
March 15, 1997
Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials
S Staszewski, A M Hill, J Bartlett, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1998
Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride
V Miller, M P de Béthune, A Kober, et al.
Intervirology
|
January 1, 1997
Increased serum and mRNA levels of RANTES associated with elevated levels of activated CD8+CD38+ T cells in HIV-1 infected individuals
P Müller, M Engelstädter, A Werner, et al.
Journal of Virology
|
April 1, 1995
Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals
D W Lineberger, J A Kessler, J A Waterbury, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Resistance profiles in patients with viral rebound on potent antiretroviral therapy
A Cozzi Lepri, C A Sabin, S Staszewski, et al.
Page
of 10